vs
Amarin Corp plc（AMRN）与Star Holdings（STHO）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是Star Holdings的1.8倍（$45.1M vs $25.4M），Amarin Corp plc净利率更高（-23.3% vs -75.5%，领先52.2%），Amarin Corp plc同比增速更快（7.0% vs -22.6%），过去两年Star Holdings的营收复合增速更高（-0.2% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
蓝星有限公司是一家印度跨国家电企业，总部位于孟买，主营空调、商用制冷以及机电工程业务，是印度本土市场规模第二大的空调领域本土企业。
AMRN vs STHO — 直观对比
营收规模更大
AMRN
是对方的1.8倍
$25.4M
营收增速更快
AMRN
高出29.6%
-22.6%
净利率更高
AMRN
高出52.2%
-75.5%
两年增速更快
STHO
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $25.4M |
| 净利润 | $-10.5M | $-19.1M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | -91.7% |
| 净利率 | -23.3% | -75.5% |
| 营收同比 | 7.0% | -22.6% |
| 净利润同比 | 33.0% | 81.3% |
| 每股收益（稀释后） | — | $-1.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNSTHO
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $25.4M | ||
| Q3 25 | $49.7M | $28.1M | ||
| Q2 25 | $72.7M | $42.1M | ||
| Q1 25 | $42.0M | $14.6M | ||
| Q4 24 | $62.3M | $32.8M | ||
| Q3 24 | $42.3M | $24.6M | ||
| Q2 24 | $67.5M | $30.6M |
净利润AMRNSTHO
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-19.1M | ||
| Q3 25 | $-7.7M | $1.8M | ||
| Q2 25 | $-14.1M | $-39.3M | ||
| Q1 25 | $-15.7M | $-7.6M | ||
| Q4 24 | $-48.6M | $-102.6M | ||
| Q3 24 | $-25.1M | $91.9M | ||
| Q2 24 | $1.5M | $-27.1M |
毛利率AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNSTHO
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -91.7% | ||
| Q3 25 | -22.4% | 1.0% | ||
| Q2 25 | -22.0% | -94.5% | ||
| Q1 25 | -39.9% | -55.0% | ||
| Q4 24 | -84.3% | -314.1% | ||
| Q3 24 | -59.5% | — | ||
| Q2 24 | -0.8% | -91.5% |
净利率AMRNSTHO
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -75.5% | ||
| Q3 25 | -15.6% | 6.4% | ||
| Q2 25 | -19.4% | -93.5% | ||
| Q1 25 | -37.4% | -52.0% | ||
| Q4 24 | -78.0% | -313.1% | ||
| Q3 24 | -59.4% | 374.3% | ||
| Q2 24 | 2.3% | -88.8% |
每股收益（稀释后）AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-1.52 | ||
| Q3 25 | $-0.02 | $0.14 | ||
| Q2 25 | $-0.03 | $-2.95 | ||
| Q1 25 | $-0.04 | $-0.57 | ||
| Q4 24 | $-0.12 | $-7.69 | ||
| Q3 24 | $-0.06 | $6.90 | ||
| Q2 24 | $0.00 | $-2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $50.1M |
| 总债务越低越好 | — | $268.7M |
| 股东权益账面价值 | — | $251.8M |
| 总资产 | $645.8M | $570.2M |
| 负债/权益比越低杠杆越低 | — | 1.07× |
8季度趋势，按日历期对齐
现金及短期投资AMRNSTHO
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $50.1M | ||
| Q3 25 | $286.6M | $40.6M | ||
| Q2 25 | $298.7M | $44.2M | ||
| Q1 25 | $281.8M | $30.3M | ||
| Q4 24 | $294.2M | $35.0M | ||
| Q3 24 | $305.7M | $45.0M | ||
| Q2 24 | $306.7M | $48.3M |
总债务AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | — | $268.7M | ||
| Q3 25 | — | $259.3M | ||
| Q2 25 | — | $245.4M | ||
| Q1 25 | — | $231.5M | ||
| Q4 24 | — | $217.3M | ||
| Q3 24 | — | $201.2M | ||
| Q2 24 | — | $197.2M |
股东权益AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $251.8M | ||
| Q3 25 | $458.9M | $275.4M | ||
| Q2 25 | $464.9M | $276.1M | ||
| Q1 25 | $473.7M | $316.1M | ||
| Q4 24 | $486.2M | $324.3M | ||
| Q3 24 | $531.4M | $427.5M | ||
| Q2 24 | $551.9M | $335.3M |
总资产AMRNSTHO
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $570.2M | ||
| Q3 25 | $659.8M | $595.9M | ||
| Q2 25 | $670.1M | $589.9M | ||
| Q1 25 | $655.7M | $618.2M | ||
| Q4 24 | $685.3M | $608.7M | ||
| Q3 24 | $750.6M | $696.5M | ||
| Q2 24 | $799.9M | $601.0M |
负债/权益比AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 0.94× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.59× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-11.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $-11.7M | ||
| Q3 25 | $-12.7M | $5.3M | ||
| Q2 25 | $16.6M | $-2.6M | ||
| Q1 25 | $-12.5M | $-6.3M | ||
| Q4 24 | $-13.3M | $-31.3M | ||
| Q3 24 | $-2.4M | $-3.8M | ||
| Q2 24 | $-2.7M | $-6.4M |
现金转化率AMRNSTHO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.04× | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
STHO
| Land Development | $13.0M | 51% |
| Other Income Revenue | $9.3M | 37% |
| Operating Lease Income | $2.0M | 8% |
| Other | $1.2M | 5% |
